| Net Cash Provided by (Used in) Operating Activities |
$1,341,000 |
USD |
96% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$19,848,000 |
USD |
-67% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$24,467,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,416,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
116,522,600 |
shares |
-88% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$43,162,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$968,929,000 |
USD |
23% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,011,267,000 |
USD |
12% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability |
$23,954,000 |
USD |
8.5% |
Q4 2025 |
Q2 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,098,820,000 |
USD |
-712% |
Q4 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$30,512,000 |
USD |
11% |
Q4 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$5,809,000 |
USD |
14% |
Q4 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$5,920,000 |
USD |
2.5% |
Q4 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$6,938,000 |
USD |
2.7% |
Q4 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$6,558,000 |
USD |
22% |
Q4 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$2,939,000 |
USD |
-38% |
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$2,846,000 |
USD |
-29% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$42,338,000 |
USD |
-63% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$27,470,000 |
USD |
-6.8% |
Q4 2025 |
Q2 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |